Drugmaker, Investors Reach $20M Settlement In Stock Drop Suit
SEATTLE — Pharmaceutical company CTI BioPharma Corp. will pay $20 million to settle claims that it, its CEO and members of its board of directors and underwriters of two of the...To view the full article, register now.
Already a subscriber? Click here to view full article